Nivolumab Combined with Ibrutinib for CLL and Richter Transformation: A Phase II Trial

被引：22
|
作者：
Jain, Nitin [1 ]
Basu, Sreyashi [2 ]
Thompson, Philip A. [1 ]
Ohanian, Maro [1 ]
Ferrajoli, Alessandra [1 ]
Pemmaraju, Naveen [1 ]
Cortes, Jorge E. [1 ]
Estrov, Zeev [1 ]
Burger, Jan A. [1 ]
Neelapu, Sattva S. [3 ]
Lopez, Wanda [1 ]
Thakral, Beenu [4 ]
Bueso-Ramos, Carlos E. [4 ]
Blando, Jorge [2 ]
O'Brien, Susan M. [5 ]
Kantarjian, Hagop M. [1 ]
Allison, James [2 ]
Keating, Michael [1 ]
Sharma, Padmanee [2 ]
Wierda, William G. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA
[2] Univ Texas MD Anderson Canc Ctr, Immunotherapy Platform, Houston, TX USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX USA
[5] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Irvine, CA USA
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.59.59
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
59
引用
收藏
页数：5
相关论文
共 50 条
  • [31] A Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin's Lymphoma
    Hanel, Walter
    Shindiapina, Polina
    Bond, David A.
    Sawalha, Yazeed
    Epperla, Narendranath
    Voorhees, Timothy
    Welkie, Rina Li
    Huang, Ying
    Behbehani, Gregory K.
    Zhang, Xiaoli
    McLaughlin, Eric
    Chan, Wing K.
    Brammer, Jonathan E.
    Jaglowski, Samantha
    Reneau, John C.
    Christian, Beth A.
    William, Basem M.
    Cohen, Jonathon B.
    Baiocchi, Robert A.
    Maddocks, Kami
    Blum, Kristie A.
    Alinari, Lapo
    CANCERS, 2023, 15 (05)
  • [32] A Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin's Lymphoma
    Hanel, Walter
    Christian, Beth A.
    Maddocks, Kami J.
    Epperla, Narendranath
    William, Basem M.
    Jaglowski, Samantha
    Bond, David A.
    Sawalha, Yazeed
    Reneau, John C.
    Brammer, Jonathan E.
    Baiocchi, Robert
    Blum, Kristie A.
    Alinari, Lapo
    BLOOD, 2020, 136
  • [33] A Phase 2 Trial of Early Intervention with Ibrutinib in Patients with Asymptomatic, High-Risk CLL
    Awan, Farrukh T.
    Thangavadivel, Shanmugapriya
    Weiss, David
    Wei, Lai
    Woyach, Jennifer A.
    Rogers, Kerry A.
    Jones, Jeffrey
    Andritsos, Leslie
    Muthusamy, Natarajan
    Andersen, Barbara
    Byrd, John C.
    BLOOD, 2017, 130
  • [34] Hodgkin's variant of Richter's transformation during ibrutinib therapy in a series of CLL patients; the Polish Adult Leukemia Group report (PALG)
    Jamroziak, Krzysztof
    Szymczyk, Agnieszka
    Hus, Marek
    Wojciechowska, Malgorzata
    Knopinska-Posluszny, Wanda
    Holojda, Jadwiga
    Halaburda, Kazimierz
    Warzocha, Krzysztof
    Iskierka-Jazdzewska, Elzbieta
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 100 (04) : 389 - 391
  • [35] Successful Treatment of Richter's Transformation with Ibrutinib in Patient with Chronic Lymphocytic Leukemia (CLL) Following Allogeneic Hematopoietic Stem Cell Transplant (HSCT)
    Master, Samip
    Leary, Cheri
    Bozeman, Amy
    Peyton-Thomas, Breanne
    Devarakonda, Srinivas
    Takalkar, Amol
    Coltelingam, James
    Mansour, Richard
    Mills, Glenn
    Koshy, Nebu
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S217 - S217
  • [36] Genetic study of Richter syndrome predicts survival after transformation of CLL
    Terre, Christine
    HEMATOLOGIE, 2011, 17 (03): : 175 - 176
  • [37] Clonality analysis of Richter's transformation in CLL treated with targeted therapy
    Xie, I.
    Rashedi, I.
    Amemiya, Y.
    Spaner, D.
    Seth, A.
    Ghorab, Z.
    Goswami, R.
    VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S51 - S51
  • [38] HODGKINS VARIANT OF RICHTER TRANSFORMATION OF CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL)
    BRECHER, M
    BANKS, PM
    LABORATORY INVESTIGATION, 1989, 60 (01) : A12 - A12
  • [39] A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms
    Owen, Dwight H.
    Benner, Brooke
    Wei, Lai
    Sukrithan, Vineeth
    Goyal, Ashima
    Zhou, Ye
    Pilcher, Carly
    Suffren, Sheryl -Ann
    Christenson, Gwen
    Curtis, Nancy
    Jukich, Megan
    Schwarz, Emily
    Savardekar, Himanshu
    Norman, Ruthann
    Ferguson, Sarah
    Kleiber, Barbara
    Wesolowski, Robert
    Carson III, William E.
    Otterson, Gregory A.
    Verschraegen, Claire F.
    Shah, Manisha H.
    Konda, Bhavana
    CLINICAL CANCER RESEARCH, 2023, 29 (04) : 731 - 741
  • [40] HAEMATOLOGICAL CANCER Richter's transformation in CLL-a distinct lymphoma
    Jain, Preetesh
    Young, Ken H.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2014, 11 (01) : 6 - 8
12345